220 related articles for article (PubMed ID: 33742126)
1. ARID2 deficiency promotes tumor progression and is associated with higher sensitivity to chemotherapy in lung cancer.
Moreno T; Monterde B; González-Silva L; Betancor-Fernández I; Revilla C; Agraz-Doblas A; Freire J; Isidro P; Quevedo L; Blanco R; Montes-Moreno S; Cereceda L; Astudillo A; Casar B; Crespo P; Morales Torres C; Scaffidi P; Gómez-Román J; Salido E; Varela I
Oncogene; 2021 Apr; 40(16):2923-2935. PubMed ID: 33742126
[TBL] [Abstract][Full Text] [Related]
2. Role of SWI/SNF chromatin remodeling genes in lung cancer development.
Monterde B; Varela I
Biochem Soc Trans; 2022 Jun; 50(3):1143-1150. PubMed ID: 35587173
[TBL] [Abstract][Full Text] [Related]
3. Recurrent inactivating mutations of ARID2 in non-small cell lung carcinoma.
Manceau G; Letouzé E; Guichard C; Didelot A; Cazes A; Corté H; Fabre E; Pallier K; Imbeaud S; Le Pimpec-Barthes F; Zucman-Rossi J; Laurent-Puig P; Blons H
Int J Cancer; 2013 May; 132(9):2217-21. PubMed ID: 23047306
[TBL] [Abstract][Full Text] [Related]
4. Chromatin remodeling gene ARID2 targets cyclin D1 and cyclin E1 to suppress hepatoma cell progression.
Duan Y; Tian L; Gao Q; Liang L; Zhang W; Yang Y; Zheng Y; Pan E; Li S; Tang N
Oncotarget; 2016 Jul; 7(29):45863-45875. PubMed ID: 27351279
[TBL] [Abstract][Full Text] [Related]
5. Chromatin remodeling factor ARID2 suppresses hepatocellular carcinoma metastasis via DNMT1-Snail axis.
Jiang H; Cao HJ; Ma N; Bao WD; Wang JJ; Chen TW; Zhang EB; Yuan YM; Ni QZ; Zhang FK; Ding XF; Zheng QW; Wang YK; Zhu M; Wang X; Feng J; Zhang XL; Cheng SQ; Ma DJ; Qiu L; Li JJ; Xie D
Proc Natl Acad Sci U S A; 2020 Mar; 117(9):4770-4780. PubMed ID: 32071245
[TBL] [Abstract][Full Text] [Related]
6. Dysregulation of SWI/SNF Chromatin Remodelers in NSCLC: Its Influence on Cancer Therapies including Immunotherapy.
Shi Y; Shin DS
Biomolecules; 2023 Jun; 13(6):. PubMed ID: 37371564
[TBL] [Abstract][Full Text] [Related]
7. BRD4 inhibition induces synthetic lethality in ARID2-deficient hepatocellular carcinoma by increasing DNA damage.
He DD; Shang XY; Wang N; Wang GX; He KY; Wang L; Han ZG
Oncogene; 2022 Mar; 41(10):1397-1409. PubMed ID: 35017665
[TBL] [Abstract][Full Text] [Related]
8. Mutations in the SWI/SNF complex induce a targetable dependence on oxidative phosphorylation in lung cancer.
Lissanu Deribe Y; Sun Y; Terranova C; Khan F; Martinez-Ledesma J; Gay J; Gao G; Mullinax RA; Khor T; Feng N; Lin YH; Wu CC; Reyes C; Peng Q; Robinson F; Inoue A; Kochat V; Liu CG; Asara JM; Moran C; Muller F; Wang J; Fang B; Papadimitrakopoulou V; Wistuba II; Rai K; Marszalek J; Futreal PA
Nat Med; 2018 Jul; 24(7):1047-1057. PubMed ID: 29892061
[TBL] [Abstract][Full Text] [Related]
9. Exome sequencing identifies ARID2 as a novel tumor suppressor in early-onset sporadic rectal cancer.
Bala P; Singh AK; Kavadipula P; Kotapalli V; Sabarinathan R; Bashyam MD
Oncogene; 2021 Jan; 40(4):863-874. PubMed ID: 33262464
[TBL] [Abstract][Full Text] [Related]
10. Targeting HSPA1A in ARID2-deficient lung adenocarcinoma.
Wang X; Wang Y; Fang Z; Wang H; Zhang J; Zhang L; Huang H; Jiang Z; Jin Y; Han X; Hou S; Zhou B; Meng F; Chen L; Wong KK; Liu J; Zhang Z; Zhang X; Chen H; Sun Y; Hu L; Ji H
Natl Sci Rev; 2021 Oct; 8(10):nwab014. PubMed ID: 34858604
[TBL] [Abstract][Full Text] [Related]
11. MiR-155-5p promotes oral cancer progression by targeting chromatin remodeling gene ARID2.
Wu M; Duan Q; Liu X; Zhang P; Fu Y; Zhang Z; Liu L; Cheng J; Jiang H
Biomed Pharmacother; 2020 Feb; 122():109696. PubMed ID: 31918270
[TBL] [Abstract][Full Text] [Related]
12. ARID2 Deficiency Correlates with the Response to Immune Checkpoint Blockade in Melanoma.
Fukumoto T; Lin J; Fatkhutdinov N; Liu P; Somasundaram R; Herlyn M; Zhang R; Nishigori C
J Invest Dermatol; 2021 Jun; 141(6):1564-1572.e4. PubMed ID: 33333124
[TBL] [Abstract][Full Text] [Related]
13. SMARCA4 and Other SWItch/Sucrose NonFermentable Family Genomic Alterations in NSCLC: Clinicopathologic Characteristics and Outcomes to Immune Checkpoint Inhibition.
Alessi JV; Ricciuti B; Spurr LF; Gupta H; Li YY; Glass C; Nishino M; Cherniack AD; Lindsay J; Sharma B; Felt KD; Rodig SJ; Cheng ML; Sholl LM; Awad MM
J Thorac Oncol; 2021 Jul; 16(7):1176-1187. PubMed ID: 33845210
[TBL] [Abstract][Full Text] [Related]
14. USP2 Inhibits Lung Cancer Pathogenesis by Reducing ARID2 Protein Degradation via Ubiquitination.
Zhu L; Chen Z; Guo T; Chen W; Zhao L; Guo L; Pan X
Biomed Res Int; 2022; 2022():1525216. PubMed ID: 36567903
[TBL] [Abstract][Full Text] [Related]
15.
Zhu G; Shi R; Li Y; Zhang Z; Xu S; Chen C; Cao P; Zhang H; Liu M; Pan Z; Liu H; Chen J
Front Immunol; 2021; 12():670040. PubMed ID: 34512623
[TBL] [Abstract][Full Text] [Related]
16. Loss of function of SWI/SNF chromatin remodeling genes leads to genome instability of human lung cancer.
Huang HT; Chen SM; Pan LB; Yao J; Ma HT
Oncol Rep; 2015 Jan; 33(1):283-91. PubMed ID: 25370573
[TBL] [Abstract][Full Text] [Related]
17. ARID2 modulates DNA damage response in human hepatocellular carcinoma cells.
Oba A; Shimada S; Akiyama Y; Nishikawaji T; Mogushi K; Ito H; Matsumura S; Aihara A; Mitsunori Y; Ban D; Ochiai T; Kudo A; Asahara H; Kaida A; Miura M; Tanabe M; Tanaka S
J Hepatol; 2017 May; 66(5):942-951. PubMed ID: 28238438
[TBL] [Abstract][Full Text] [Related]
18. Altered BAF occupancy and transcription factor dynamics in PBAF-deficient melanoma.
Carcamo S; Nguyen CB; Grossi E; Filipescu D; Alpsoy A; Dhiman A; Sun D; Narang S; Imig J; Martin TC; Parsons R; Aifantis I; Tsirigos A; Aguirre-Ghiso JA; Dykhuizen EC; Hasson D; Bernstein E
Cell Rep; 2022 Apr; 39(1):110637. PubMed ID: 35385731
[TBL] [Abstract][Full Text] [Related]
19. Loss of ARID1A expression promotes lung adenocarcinoma metastasis and predicts a poor prognosis.
Sun D; Zhu Y; Zhao H; Bian T; Li T; Liu K; Feng L; Li H; Hou H
Cell Oncol (Dordr); 2021 Oct; 44(5):1019-1034. PubMed ID: 34109546
[TBL] [Abstract][Full Text] [Related]
20. Arid2 regulates hematopoietic stem cell differentiation in normal hematopoiesis.
Bluemn T; Schmitz J; Chen Y; Zheng Y; Zhang Y; Zheng S; Burns R; DeJong J; Christiansen L; Izaguirre-Carbonell J; Wang D; Zhu N
Exp Hematol; 2021 Feb; 94():37-46. PubMed ID: 33346030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
